A Prospective, Multi-center, Open-labeled, Randomized Clinical Trial of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant Recipients to Compare QD Early Conversion and BID Tacrolimus Formulation.
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2018
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 30 Jul 2018 Status changed from not yet recruiting to recruiting.
- 07 Aug 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.
- 18 Jul 2017 New trial record